Seite auswählen

The expiring patents of branded pharmaceuticals have had a positive effect on the sales revenues in the generics industry, to the effect of $37 billion.

Alone in 2012, pharmaceutical brands stand to lose $37 billion in sales revenue, as their patent protection expires. Consultant firm Frost & Sullivan predict that by 2018, sales in the generics industry will reach $231 billion; in 2010, this figure was  $124 billion.

[ilink url=“http://www.deutsche-gesundheits-nachrichten.de/2012/08/31/2012-gutes-jahr-fur-generikahersteller/“]Link zur Quelle (Deutsche Gesundheits Nachrichten)[/ilink]